🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users injecting products of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

According to TikTok, the service has removed violative content and banned related keywords and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at residence.

After minutes of entering one group, a seller posted contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Item Details and Costs

Inside these communities, posts show black plastic packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.